Evidence map›Paper›PMID 42277675›Full record

ArticleBMC cardiovascular disorders2026

Trends in cardiac implantable electronic device infections: 2015 to 2019.

Benito Baldauf, Kerstin Bode, Ernest W Lau, Marzia Giaccardi, Ojan Assadian, Philippe Chévalier, Christelle Haddad, Andreas Klöss, Roberto Cemin, Reinhard Vonthein and 1 more

Abstract read
In one paragraph

Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Benito Baldauf *Institute of Life Sciences, Hochschule Bremerhaven, University of Applied Sciences, An der Karlstadt 8, Bremerhaven, 27568, Germany. bbaldauf@hs-bremerhaven.de.
Kerstin Bode *Department of Electropyhsiology, Herzzentrum Leipzig, Strümpellstraße 39, Leipzig, 04289, Germany.
Ernest W LauDepartment of Cardiology, Royal Victoria Hospital, Grosvenor Road, Belfast, BT12 6BA, UK.
Marzia GiaccardiDepartment of Cardiology, Ospedale Santa Maria Annunziata, Ponte a Niccheri, Florence, 50012, Italy.
Ojan AssadianUniversity Hospital Wiener Neustadt, Corvinusring 3-5, Wiener Neustadt, 2700, Austria.
Philippe ChévalierDepartment of Cardiology, Hôpital Louis Pradel, 59 Bd Pinel, Bron, 69500, France.
Christelle HaddadDepartment of Cardiology, Hôpital Louis Pradel, 59 Bd Pinel, Bron, 69500, France.
Andreas KlössResearch Institute of the Local Health Care Funds, Berlin, Germany.
Roberto CeminIntensive care unit, Ospedale Regionale San Maurizio, Via Lorenz Böhler 5, Bolzano, 39100, Italy.
Reinhard VontheinInstitut für Medizinische Biometrie und Statistik, Universität zu Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany.
Hendrik BonnemeierMedical Faculty, Christian-Albrechts University, Christian- Albrechts-Platz 4, Kiel, 24118, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiovascular implantable electronic devices (CIEDs) improve survival in patients with cardiac rhythm disorders but carry risks of complications, most notably major infections. Reported infection rates vary internationally, and contemporary large-scale data from Germany are scarce. We aimed to determine nationwide rates of CIED infection-related hospitalizations and associated mortality over a five-year period.

methodsWe analyzed administrative claims from Germany's largest statutory health insurer covering more than 27 million beneficiaries. All CIED procedures performed between January 2015 and December 2019 were identified, including initial implantations, upgrades or downgrades, generator replacements, early revisions, and device extractions. Major infections were detected using International Classification of Diseases (ICD-10-GM) and procedural codes, and stratified as generator pocket infections or lead-associated endocarditis. In-hospital mortality was determined from discharge records.

resultsAmong 282,205 patients (57.7% male) undergoing CIED procedures, 6,577 individuals (2.33%) experienced 7,704 major infections within three months. Generator pocket infections occurred in 5,396 cases (1.91%), lead-associated endocarditis in 2,308 (0.82%), and combined infections in 1,127 patients (0.39%) within the acute 90-day observation period. CIED infections substantially increased healthcare utilization: Infected patients required substantially more procedures than non-infected patients, despite correct treatment. In-hospital mortality reached 8.36% for pocket infections and 15.0% for endocarditis. Extended follow-up in the 2015 cohort revealed a 4.33% infection-related procedure rate over five years.

conclusionsNationwide German data reveal higher acute CIED infection rates than previously reported, with considerable mortality and procedural burden. These findings highlight an urgent need for improved prevention and management strategies.

Indexed as

Cardiac Resynchronization Therapy DevicesDefibrillators, ImplantableElectric CountershockPacemaker, ArtificialProsthesis ImplantationProsthesis-Related InfectionsAdministrative Claims, HealthcareAgedAged, 80 and overDatabases, FactualDevice Lead ExtractionDevice RemovalFemaleGermanyHospital MortalityHumansCardiac implantable electronic deviceEpidemiologyHealth claim dataInfectionMortality rate

Identifiers

PMID42277675
PMCPMC13262421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.